SG46291G - Novel alpha, alpha-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, n-oxides - Google Patents

Novel alpha, alpha-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, n-oxides

Info

Publication number
SG46291G
SG46291G SG46291A SG46291A SG46291G SG 46291 G SG46291 G SG 46291G SG 46291 A SG46291 A SG 46291A SG 46291 A SG46291 A SG 46291A SG 46291 G SG46291 G SG 46291G
Authority
SG
Singapore
Prior art keywords
alpha
6alkyl
compounds
piperidinebutanamide
diaryl
Prior art date
Application number
SG46291A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SG46291G publication Critical patent/SG46291G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Compositions Of Oxide Ceramics (AREA)
SG46291A 1985-10-11 1991-06-18 Novel alpha, alpha-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, n-oxides SG46291G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78656685A 1985-10-11 1985-10-11

Publications (1)

Publication Number Publication Date
SG46291G true SG46291G (en) 1991-07-26

Family

ID=25138953

Family Applications (1)

Application Number Title Priority Date Filing Date
SG46291A SG46291G (en) 1985-10-11 1991-06-18 Novel alpha, alpha-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, n-oxides

Country Status (33)

Country Link
EP (1) EP0219898B1 (nl)
JP (1) JPS6287569A (nl)
KR (1) KR940001772B1 (nl)
CN (1) CN1015453B (nl)
AT (1) ATE53022T1 (nl)
AU (1) AU583429B2 (nl)
BG (1) BG61320B2 (nl)
CA (1) CA1332236C (nl)
CY (1) CY1603A (nl)
DE (1) DE3671442D1 (nl)
DK (1) DK173954B1 (nl)
DZ (1) DZ997A1 (nl)
EG (1) EG18126A (nl)
ES (1) ES2002001A6 (nl)
FI (1) FI83642C (nl)
GR (1) GR862493B (nl)
HK (1) HK52491A (nl)
HU (1) HU196180B (nl)
IE (1) IE59519B1 (nl)
IL (1) IL80268A (nl)
LT (1) LT2086B (nl)
LV (2) LV5042A3 (nl)
NL (1) NL950025I2 (nl)
NO (2) NO168640C (nl)
NZ (1) NZ217818A (nl)
PH (1) PH22510A (nl)
PT (1) PT83506B (nl)
SG (1) SG46291G (nl)
SU (1) SU1443798A3 (nl)
TN (1) TNSN86138A1 (nl)
ZA (1) ZA867713B (nl)
ZM (1) ZM9486A1 (nl)
ZW (1) ZW20386A1 (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002223A1 (en) * 1990-08-09 1992-02-20 The Procter & Gamble Company Process for formulating a solid oral dosage form of loperamide compounds
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
WO1997024325A1 (en) * 1995-12-28 1997-07-10 Takeda Chemical Industries, Ltd. DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS
CA2322136A1 (en) * 1998-03-06 1999-09-10 Ludo Edmond Josephine Kennis Glycine transport inhibitors
KR101315751B1 (ko) * 2011-05-30 2013-10-10 주식회사 엔지켐생명과학 로페라미드 옥사이드 모노하이드레이트의 신규한 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714159A (en) * 1971-03-30 1973-01-30 Janssen Pharmaceutica Nv 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piper-idino)-butyramides
US4002618A (en) * 1976-02-23 1977-01-11 G. D. Searle & Co. 2,2-Diphenyl-5-(4-substituted-piperidino)-3-trans-pentenenitriles

Also Published As

Publication number Publication date
DE3671442D1 (de) 1990-06-28
ZA867713B (en) 1988-05-25
DK173954B1 (da) 2002-03-04
NO168640C (no) 1992-03-18
TNSN86138A1 (fr) 1990-01-01
NL950025I2 (nl) 1997-03-03
ATE53022T1 (de) 1990-06-15
DK486886A (da) 1987-04-12
HK52491A (en) 1991-07-19
DZ997A1 (fr) 2004-09-13
AU6381586A (en) 1987-04-16
IE59519B1 (en) 1994-03-09
CA1332236C (en) 1994-10-04
FI83642B (fi) 1991-04-30
IE862677L (en) 1987-04-11
EP0219898B1 (en) 1990-05-23
LV5767B4 (lv) 1997-06-20
CN86106848A (zh) 1987-04-08
HUT42444A (en) 1987-07-28
FI864099A (fi) 1987-04-12
LT2086B (lt) 1993-07-15
NL950025I1 (nl) 1996-01-02
GR862493B (en) 1987-02-03
LV5042A3 (lv) 1993-06-10
KR940001772B1 (ko) 1994-03-05
JPS6287569A (ja) 1987-04-22
IL80268A (en) 1991-03-10
NO864045L (no) 1987-04-13
NO1996010I1 (no) 1996-08-06
IL80268A0 (en) 1987-01-30
FI83642C (fi) 1991-08-12
FI864099A0 (fi) 1986-10-10
NZ217818A (en) 1989-03-29
DK486886D0 (da) 1986-10-10
NO864045D0 (no) 1986-10-10
EP0219898A1 (en) 1987-04-29
KR870003986A (ko) 1987-05-06
PT83506B (pt) 1989-02-28
ES2002001A6 (es) 1988-07-01
BG61320B2 (bg) 1997-05-30
ZM9486A1 (en) 1988-04-29
PT83506A (en) 1986-11-01
ZW20386A1 (en) 1988-05-11
JPH0517909B2 (nl) 1993-03-10
LV5767A4 (lv) 1996-12-20
PH22510A (en) 1988-09-12
NO168640B (no) 1991-12-09
SU1443798A3 (ru) 1988-12-07
CY1603A (en) 1992-04-03
CN1015453B (zh) 1992-02-12
EG18126A (en) 1992-08-30
AU583429B2 (en) 1989-04-27
HU196180B (en) 1988-10-28

Similar Documents

Publication Publication Date Title
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
ES8802151A1 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
HUT43051A (en) Process for preparing pyridine-carboxylic acid derivatives and pharmaceutical compositions containing thereof as active ingredients
NZ233525A (en) Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers and pharmaceutical compositions
EG18126A (en) Novel alpha,alpha-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamides,n-oxides
PT91613A (pt) Process for the preparation of antihypertensive 3-piperidinyl-indazole derivatives